Genor Biopharma Co. Ltd. was founded in December 2007. It is an innovation-driven international biopharmaceutical company, focusing on development and commercialization of therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins. Currently Genor has more than 10 products in pipeline, ten of which have entered clinical stage.

Genor Biopharma has several product in the clinical and preclinical stage (including biosimilar and innovative drugs). We are activily seeking collaboration partnerships to co-develop emerging market and EU/US markets.

If you are interested in such collaboration opportunities, please contact our business development department. We are sincerly looking forward to the partnership oportunites to enrich our pipeline, and t o accelerate product development  and commercialization.

Email: [email protected]